FUNCTIONAL AREAS – Page 50

Artwork change error during supplier change – documentation gaps regulators question

The symptoms of an artwork change error can manifest in various ways, often first detected on the production floor or during quality control evaluations. Key signals include:Click to read the…

CSV not aligned to actual use during system operation – inspection evidence pack preparation

Identifying symptoms or signals that indicate a misalignment of CSV is the first step in the investigation process. These can manifest in various ways, including:Click to read the full article.

Extractables and leachables concern during supplier change – inspection evidence expectations

Identifying signals indicative of E&L concerns is paramount. Symptoms may manifest during routine testing or as part of product stability studies. Common observations may include:Click to read the full article.

Interface validation gaps during data integrity review – FDA/EMA expectations for computerized systems

Recognizing symptoms of interface validation gaps is critical in the pharmaceutical environment. Symptoms may manifest in several areas, including:Click to read the full article.

Packaging compatibility risk during inspection readiness – regulatory risk analysis and mitigation

Early identification of packaging compatibility risks is vital in reducing the likelihood of regulatory scrutiny. Symptoms may manifest as deviations, out-of-specification (OOS) results, or direct complaints from quality teams. Common…

Patch management weaknesses during system upgrades – data integrity risk and remediation

Recognizing early symptoms of patch management weaknesses is pivotal. Symptoms may not only emerge in IT but can also cascade into production areas, affecting quality assurance and regulatory compliance. Common…

Material specification drift during scale-up – documentation gaps regulators question

The early detection of symptoms correlated to material specification drift is critical for initiating timely investigations. Signals can manifest in various forms, both in manufacturing and laboratory settings:Click to read…

Interface validation gaps during system upgrades – CAPA and revalidation strategy

Identifying symptoms or signals indicative of validation gaps is the first step in addressing potential issues. Common symptoms may include:Click to read the full article.

Container closure integrity risk during inspection readiness – regulatory risk analysis and mitigation

Analyzing Container Closure Integrity Risks During Inspection Readiness Container closure integrity (CCI) is a critical quality attribute in pharmaceutical manufacturing, as it directly impacts product sterility and stability. Instances of…

Interface validation gaps during system operation – CAPA and revalidation strategy

Identifying symptoms indicative of interface validation gaps is the first critical step in the investigation process. Symptoms may manifest in various forms and can often be overlooked if not carefully…

Inventory control failure during storage – documentation pack for auditors

Inventory control failures can manifest through various symptoms and signals, which can be observed on the manufacturing floor or in laboratory settings. Recognizing these symptoms promptly is key to initiating…

Patch management weaknesses during inspection walkthrough – data integrity risk and remediation

Identifying and Addressing Patch Management Weaknesses During Inspection Walkthroughs Poor patch management can expose pharmaceutical manufacturers to significant compliance risks, particularly during regulatory inspections conducted by agencies such as the…